Development of neuro-fuzzy model to explore gene-nutrient interactions modulating warfarin dose requirement.

about

Development of neuro-fuzzy model to explore gene-nutrient interactions modulating warfarin dose requirement.

Item

http://www.wikidata.org/entity/Q47688705

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Development of neuro-fuzzy mod ...... ing warfarin dose requirement.

@en

Development of neuro-fuzzy mod ...... ing warfarin dose requirement.

@nl

type

Item

label

Development of neuro-fuzzy mod ...... ing warfarin dose requirement.

@en

Development of neuro-fuzzy mod ...... ing warfarin dose requirement.

@nl

prefLabel

Development of neuro-fuzzy mod ...... ing warfarin dose requirement.

@en

Development of neuro-fuzzy mod ...... ing warfarin dose requirement.

@nl

P1476

Development of neuro-fuzzy mod ...... ing warfarin dose requirement.

@en

P2093

Addepalli Pavani

http://www.w3.org/2001/XMLSchema#string

Amaresh Rao Malempati

http://www.w3.org/2001/XMLSchema#string

Balraj Alex Stanley

http://www.w3.org/2001/XMLSchema#string

Ganapathy Lakshmitha

http://www.w3.org/2001/XMLSchema#string

Sriraman Nivetha

http://www.w3.org/2001/XMLSchema#string

Vijay Kumar Kutala

http://www.w3.org/2001/XMLSchema#string

P2860

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Estimation of the warfarin dose with clinical and pharmacogenetic data.

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

Functional study of the vitamin K cycle in mammalian cells.

Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.

Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2

Association of warfarin dose with genes involved in its action and metabolism.

Influence of vitamin K on anticoagulant therapy depends on vitamin K status and the source and chemical forms of vitamin K.

Association Between Usual Vitamin K Intake and Anticoagulation in Patients Under Warfarin Therapy.

P304

1315-1325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS-2016-0058

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shaik Mohammad Naushad

P577

2016-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27462768

http://www.w3.org/2001/XMLSchema#string